Revelation Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $10.7M | $6.5M | $12.0M | $5.3M | $1.3M | $11.7K | — |
| Accounts Receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $10.8M | $6.6M | $12.1M | $5.4M | $1.9M | $651.3K | $22.7K |
| Property, Plant & Equipment | $18.1K | $56.3K | $65.1K | $90.1K | $115.2K | — | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $11.6M | $6.6M | $12.2M | $5.5M | $2.0M | $74.2M | $22.7K |
| Liabilities | |||||||
| Accounts Payable | $577.5K | $783.6K | $1.4M | $554.2K | $596.3K | $33.8K | — |
| Total Current Liabilities | $2.0M | $1.9M | $5.6M | $4.5M | $2.1M | $3.4M | $26.3K |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $2.7M | $1.9M | $5.6M | $4.5M | $2.1M | $6.3M | $26.3K |
| Stockholders' Equity | |||||||
| Retained Earnings | $-49.4M | $-40.5M | $-25.5M | $-25.3M | $-14.5M | $-5.7M | $-3.6K |
| Total Stockholders' Equity | $8.9M | $4.7M | $6.6M | $1.1M | $-99.5K | $3.4M | $-3.6K |